Joshua T Brumm Dyne Therapeutics, Inc. (DYN) insider trading activity

Joshua T Brumm is CEO & President of Dyne Therapeutics, Inc.. Currently has a direct ownership of 537,998 shares of DYN, which is worth approximately $7.28 Million. The most recent transaction as insider was on Mar 14, 2023, when has been sold 7,318 shares (Common Stock) at a price of $13.33 per share, resulting in proceeds of $97,548. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 538K

0% 3M change

4.52% 12M change

Total Value Held $7.28 Million

Joshua T Brumm Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 14 2023	SELL Open market or private sale	$97,548 $13.33 p/Share	7,318 Reduced 2.22%	322,483 Common Stock
Dec 12 2022	SELL Open market or private sale	$36,110 $10.87 p/Share	3,322 Reduced 1.0%	329,801 Common Stock
Dec 09 2022	BUY Grant, award, or other acquisition	-	144,000 Added 30.18%	333,123 Common Stock
Oct 10 2022	SELL Open market or private sale	$2,439,668 $12.46 p/Share	195,800 Reduced 48.9%	204,623 Common Stock
Oct 10 2022	SELL Bona fide gift	-	15,500 Reduced 7.57%	189,123 Common Stock
Oct 10 2022	BUY Exercise of conversion of derivative security	$201,674 $1.03 p/Share	195,800 Added 32.84%	400,423 Common Stock
Oct 07 2022	SELL Open market or private sale	$189,854 $13.37 p/Share	14,200 Reduced 6.49%	204,623 Common Stock
Oct 07 2022	BUY Exercise of conversion of derivative security	$14,626 $1.03 p/Share	14,200 Added 6.09%	218,823 Common Stock
Sep 20 2022	SELL Sale (or disposition) back to the issuer	$162,153 $13.7 p/Share	11,836 Reduced 5.47%	204,623 Common Stock
Sep 15 2022	SELL Sale (or disposition) back to the issuer	$48,894 $14.05 p/Share	3,480 Reduced 1.58%	216,459 Common Stock
Jul 06 2022	SELL Sale (or disposition) back to the issuer	$90,335 $8.24 p/Share	10,963 Reduced 4.75%	219,939 Common Stock
Jul 05 2022	BUY Grant, award, or other acquisition	-	24,118 Added 9.46%	230,902 Common Stock
Jun 14 2022	SELL Sale (or disposition) back to the issuer	$17,523 $4.95 p/Share	3,540 Reduced 1.68%	206,784 Common Stock
Mar 11 2022	SELL Open market or private sale	$29,542 $8.73 p/Share	3,384 Reduced 1.58%	210,324 Common Stock
Dec 10 2021	BUY Grant, award, or other acquisition	-	118,190 Added 35.61%	213,708 Common Stock
Oct 01 2021	SELL Bona fide gift	-	3,500 Reduced 3.53%	95,518 Common Stock
Sep 21 2021	SELL Open market or private sale	$73,848 $16.11 p/Share	4,584 Reduced 4.42%	99,018 Common Stock
Sep 20 2021	SELL Open market or private sale	$53,464 $15.61 p/Share	3,425 Reduced 3.2%	103,602 Common Stock

JTB

Joshua T Brumm

CEO & President

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Value

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Dyne Therapeutics, Inc.

Track Activities on DYN

Account